![]() |
Name |
Fusariumester C
|
Molecular Formula | C36H58O11 | |
IUPAC Name* |
14-[14-carboxy-3,12-dihydroxy-2-(hydroxymethyl)-8,10-dimethyltetradeca-10,12-dienoyl]oxy-13-hydroxy-3,5,7-trimethylpentadeca-2,4-dienedioicacid
|
|
SMILES |
CC(=CC(=O)O)C=C(C)CC(C)CCCCC(O)C(COC(=O)C(CO)C(O)CCCCC(C)CC(C)=CC(C)=CC(=O)O)C(=O)O
|
|
InChI |
InChI=1S/C36H58O11/c1-23(15-25(3)17-27(5)19-33(40)41)11-7-9-13-31(38)29(21-37)36(46)47-22-30(35(44)45)32(39)14-10-8-12-24(2)16-26(4)18-28(6)20-34(42)43/h17-20,23-24,29-32,37-39H,7-16,21-22H2,1-6H3,(H,40,41)(H,42,43)(H,44,45)/b25-17+,26-18+,27-19+,28-20+/t23-,24-,29+,30+,31-,32-/m1/s1
|
|
InChIKey |
FUQPNMATXFLBKB-JPXDQTBVSA-N
|
|
Synonyms |
NA
|
|
CAS | NA | |
PubChem CID | NA | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 666.85 | ALogp: | 5.7 |
HBD: | 6 | HBA: | 8 |
Rotatable Bonds: | 25 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 198.9 | Aromatic Rings: | 0 |
Heavy Atoms: | 47 | QED Weighted: | 0.03 |
Caco-2 Permeability: | -5.965 | MDCK Permeability: | 0.00000829 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0.955 |
Human Intestinal Absorption (HIA): | 0.991 | 20% Bioavailability (F20%): | 0.085 |
30% Bioavailability (F30%): | 0.83 |
Blood-Brain-Barrier Penetration (BBB): | 0.029 | Plasma Protein Binding (PPB): | 91.52% |
Volume Distribution (VD): | 0.428 | Fu: | 3.46% |
CYP1A2-inhibitor: | 0.027 | CYP1A2-substrate: | 0.06 |
CYP2C19-inhibitor: | 0.017 | CYP2C19-substrate: | 0.056 |
CYP2C9-inhibitor: | 0.046 | CYP2C9-substrate: | 0.977 |
CYP2D6-inhibitor: | 0.051 | CYP2D6-substrate: | 0.114 |
CYP3A4-inhibitor: | 0.015 | CYP3A4-substrate: | 0.012 |
Clearance (CL): | 1.168 | Half-life (T1/2): | 0.946 |
hERG Blockers: | 0.013 | Human Hepatotoxicity (H-HT): | 0.802 |
Drug-inuced Liver Injury (DILI): | 0.563 | AMES Toxicity: | 0.001 |
Rat Oral Acute Toxicity: | 0.007 | Maximum Recommended Daily Dose: | 0.479 |
Skin Sensitization: | 0.969 | Carcinogencity: | 0.159 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.016 |
Respiratory Toxicity: | 0.043 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC005666 | ![]() |
0.885 | D0D9NY | ![]() |
0.229 | ||
ENC005667 | ![]() |
0.803 | D0TP2W | ![]() |
0.227 | ||
ENC005668 | ![]() |
0.752 | D0X4FM | ![]() |
0.227 | ||
ENC005669 | ![]() |
0.531 | D0RQ2W | ![]() |
0.223 | ||
ENC005670 | ![]() |
0.434 | D03JSJ | ![]() |
0.221 | ||
ENC006085 | ![]() |
0.354 | D00FSV | ![]() |
0.213 | ||
ENC001858 | ![]() |
0.308 | D0C3LP | ![]() |
0.211 | ||
ENC001818 | ![]() |
0.284 | D01OIL | ![]() |
0.203 | ||
ENC001412 | ![]() |
0.284 | D0ZI4H | ![]() |
0.200 | ||
ENC005267 | ![]() |
0.276 | D0AT8C | ![]() |
0.200 |